HIIFS
WST icon

Harel Insurance Investments & Financial Services’s West Pharmaceutical WST Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,120
Closed -$475K – 508
2025
Q1 		$475K Buy
+2,120
New +$584K 0.01% 202
2022
Q2 		– Sell
-99
Closed -$41K – 808
2022
Q1 		$41K Hold
99
– – ﹤0.01% 543
2021
Q4 		$47K Hold
99
– – ﹤0.01% 594
2021
Q3 		$42K Sell
99
-729
-88% -$307K ﹤0.01% 549
2021
Q2 		$969K Sell
828
-541
-40% -$179K 0.02% 327
2021
Q1 		$1.29M Buy
1,369
+208
+18% +$59.5K 0.02% 314
2020
Q4 		$1.06M Buy
1,161
+99
+9% +$27.8K 0.03% 275
2020
Q3 		$292K Buy
+1,062
New +$281K 0.01% 251

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Harel Insurance Investments & Financial Services's WST Position: Q2 2025 in Review

Harel Insurance Investments & Financial Services sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 2,120 shares — an estimated $475K sold.

Harel Insurance Investments & Financial Services first reported a position in WST in Q3 2020 and held it in 8 quarters. The position peaked at $1.29M in Q1 2021. 731 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Harel Insurance Investments & Financial Services reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 2,120 West Pharmaceutical shares in Q2 2025, an estimated $475K.
  • Harel Insurance Investments & Financial Services first reported a position in West Pharmaceutical in Q3 2020 and held it in 8 quarters.
  • Harel Insurance Investments & Financial Services's West Pharmaceutical position peaked at $1.29M in Q1 2021.
  • 731 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2025, filed 5 Aug 2025.